CANbridge to Continue CAN008 Phase 2 Trial in Glioblastoma M

CANbridge to Continue CAN008 Phase 2 Trial in Glioblastoma Multiforme (GBM) in China Based on Interim Analysis of Independent Data Monitoring Committee

CANbridge to Continue CAN008 Phase 2 Trial in Glioblastoma Multiforme (GBM) in China Based on Interim Analysis of Independent Data Monitoring Committee

itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

China , United States , American , Chris Brinzey , James Xue , Planet Communications , Development Facility , European Society For Gene , American Society For Gene , University Of Washington School Medicine , Canbridge Pharmaceuticals Inc , Umass Chan Medical School , World Muscle Congress , National Medical Products Administration , European Medicines Agency , Drug Designation , Orphan Medicinal Product Designation , Priority Medicines , National Medical Products , Greater China , Next Generation Innovation , Process Development Facility , American Society , Cell Therapy , European Society , World Muscle , Wuxi Biologics , Chan Medical School , Washington School , Pharmaceuticals Inc ,